Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell Carcinoma
出版年份 2021 全文链接
标题
Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell Carcinoma
作者
关键词
-
出版物
Cancers
Volume 13, Issue 18, Pages 4511
出版商
MDPI AG
发表日期
2021-09-08
DOI
10.3390/cancers13184511
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2021) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
- (2021) Gorka Larrinaga et al. Cancers
- Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma
- (2020) Caroline Roelants et al. Cancers
- Tumor slice culture as a biologic surrogate of human cancer
- (2020) Heidi L. Kenerson et al. Annals of Translational Medicine
- Tumor organoid models in precision medicine and investigating cancer-stromal interactions
- (2020) Ren Xu et al. PHARMACOLOGY & THERAPEUTICS
- Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma
- (2020) Miriam Ficial et al. CLINICAL CANCER RESEARCH
- The first-week proliferative response of peripheral blood PD-1+CD8+ T cells predicts the response to anti-PD-1 therapy in solid tumors
- (2019) Kyung Hwan Kim et al. CLINICAL CANCER RESEARCH
- irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
- (2019) Jean-Christophe Pignon et al. CLINICAL CANCER RESEARCH
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
- (2019) Guoping Ding et al. BMC CANCER
- Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer
- (2019) Steve Z. Martin et al. BMC CANCER
- Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients
- (2019) Tuba N. Gide et al. OncoImmunology
- Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
- (2019) Philipp J. Stenzel et al. Translational Oncology
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis
- (2018) Lijin Zhang et al. BMC CANCER
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
- (2017) Alice O. Kamphorst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy
- (2017) Elisa Peranzoni et al. Jove-Journal of Visualized Experiments
- PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
- (2017) Sylvain Simon et al. OncoImmunology
- Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment
- (2017) Xiuyun Jiang et al. OncoImmunology
- Renal cancer
- (2016) Umberto Capitanio et al. LANCET
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study
- (2016) Saeed Dabestani et al. WORLD JOURNAL OF UROLOGY
- A Threshold Level of Intratumor CD8 + T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1
- (2015) Shin Foong Ngiow et al. CANCER RESEARCH
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
- (2015) Roberto Iacovelli et al. Targeted Oncology
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
- (2014) L.B. Jilaveanu et al. Journal of Cancer
- The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma
- (2013) Daniel Weissinger et al. Molecular Cancer
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started